1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Blood Loss, Postoperative in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ereth, MH; Harmsen, WS; Klindworth, JT; MacVeigh, I; Nuttall, GA; Oliver, WC; Orszulak, TA; Santrach, PJ | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Blood Loss, Postoperative
| Article | Year |
|---|---|
Does the platelet-activated clotting test (HemoSTATUS) predict blood loss and platelet dysfunction associated with cardiopulmonary bypass?
Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Blood Loss, Surgical; Blood Platelets; Cardiopulmonary Bypass; Coronary Artery Bypass; Female; Forecasting; Heart Defects, Congenital; Heart Valves; Heparin Antagonists; Humans; Male; Mediastinum; Partial Thromboplastin Time; Platelet Activating Factor; Platelet Activation; Platelet Count; Point-of-Care Systems; Postoperative Hemorrhage; Protamines; Prothrombin Time; Reoperation; Retrospective Studies; Sensitivity and Specificity; Thrombelastography | 1997 |